Histopathological effects of androgen deprivation in prostatic cancer

Seminars in Urologic Oncology

Volumn 14, Issue 2 SUPPL. 2, 1996, Pages 22-31

  Civantos, F ^a   Soloway, M S ^a   Pinto, J E ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

hormone therapy; pathology; Prostate cancer

Indexed keywords

ANDROGEN; FINASTERIDE; FLUTAMIDE; LEUPRORELIN; PROSTATE SPECIFIC ANTIGEN;

ARTICLE; CANCER GRADING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; TREATMENT OUTCOME;

ADENOCARCINOMA; ANDROGEN ANTAGONISTS; ANTINEOPLASTIC AGENTS, HORMONAL; COMBINED MODALITY THERAPY; FLUTAMIDE; HUMANS; LEUPROLIDE; MALE; NEOPLASM STAGING; PREMEDICATION; PROSTATECTOMY; PROSTATIC NEOPLASMS;

EID: 0029888406     PISSN: 10810943     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)